OGN:NYSE, Organon & Co.

OGN stock overview

Organon & Co. (OGN:NYSE) closed at $13.89 on November 20, 2026, down 0.14% on the day. The stock trades 0.4% below its 52-week high of $13.94 and 144.1% above its 52-week low of $5.69. Over the past year, it gained 96.7%. Organon & Co. is part of the Health Care sector.

Key figures

Price
$13.89
Day change
-0.14%
Volume
3,572,950
Average volume
2,712,434
Market cap
3B+
52-week range
$5.69 – $13.94
50-day average
$13.77
200-day average
$11.87

Price action over the past year

In 252 trading sessions since November 20, 2025, OGN closed higher on 123 days (49%). Its best day was April 24, 2026 (+30.93%) and its worst was February 12, 2026 (-8.19%). The stock moved 10% or more in a single session 4 times. It opened at least 5% above the previous day's high 3 times.

Recent signals

OGN news

About Organon & Co.

Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. Its two operating segments are the Organon Products segment and the Merck Retained Products segment. It operates in the United States, China, Japan, Korea, and countries in Europe.

Similar stocks

Find more stocks like OGN with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.